Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
Source: Press Release
Edmonton-based Metabolomic Technologies Inc, a developer of metabolomics-based in-vitro diagnostics, has raised $4.2 million in Series A funding. The investors were not named.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination